UAS regulatory sequences drive expression of an inverted repeat.
The expression of tbcJF03204 under the control of Scer\GAL4SPARC-MI00329-GAL4 (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion, including intracellular matrix material, as shown by the retention of both secr.GFP and Vkg.GFP.
Scer\GAL4SPARC-MI00329-GAL4, tbcJF03204 has embryonic/larval fat body | third instar larval stage phenotype, non-suppressible by Rab26UAS.YFP, Scer\GAL4SPARC-MI00329-GAL4
Scer\GAL4SPARC-MI00329-GAL4, tbcJF03204 has extracellular matrix | third instar larval stage phenotype, non-suppressible by Rab26UAS.YFP, Scer\GAL4SPARC-MI00329-GAL4
Rab26T204N.UAS.YFP, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
RabX6UASp.YFP, Scer\GAL4Cg.PA, tbcJF03204 has embryonic/larval fat body | third instar larval stage phenotype
RabX6UASp.YFP, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
Rab26JF01684, Scer\GAL4Cg.PA, tbcJF03204 has embryonic/larval fat body | third instar larval stage phenotype
Rab26JF01684, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
RabX6M69L.UASp.YFP, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
RabX6S22N.UAS.YFP, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
RabX6JF02050, Scer\GAL4Cg.PA, tbcJF03204 has embryonic/larval fat body | third instar larval stage phenotype
RabX6JF02050, Scer\GAL4Cg.PA, tbcJF03204 has extracellular matrix | third instar larval stage phenotype
The co-expression of tbcJF03204 and Rab26T204N.UAS.YFP under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.
The co-expression of tbcJF03204 and Rab26JF01684 under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.
The co-expression of tbcJF03204 and RabX6M69L.UASp.YFP under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.
The co-expression of tbcJF03204 and RabX6S22N.UAS.YFP under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.
The co-expression of tbcJF03204 and RabX6JF02050 under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.
The co-expression of tbcJF03204 and RabX6UASp.YFP under the control of Scer\GAL4Cg.PA (and Dicer-2, for a more efficient RNAi) in the larval fat body induces defective secretion of intracellular matrix material, as shown by the retention of Vkg.GFP.